Argentine regulator approves AstraZeneca/Oxford COVID-19 vaccine -AstraZeneca


  • World
  • Thursday, 31 Dec 2020

(Reuters) - Argentina's regulator on Wednesday approved the COVID-19 vaccine developed by AstraZeneca and Oxford University for emergency use, AstraZeneca said in a statement.

AstraZeneca said the approval by the National Administrator for Food and Medical Technology (ANMAT) made Argentina "one of the first countries in the world to authorize" the drug, after the UK regulator gave the green light for its widespread roll-out earlier on Wednesday.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Others Also Read


All Headlines:

Want to listen to full audio?

Unlock unlimited access to enjoy personalise features on the TheStar.com.my

Already a member? Log In